Israeli biotech company finds 100 % cure cancer

Israeli biotech company finds 100 % cure for cancer

9:30 AM, 1st February 2019
cancer

NES ZIONA, ISRAEL: At a time when cancer is spreading at a disturbingly fast pace across the globe, an Israeli biotech company have claimed that they will have the cure for this deadly disease by 2020. 
Although different types of treatments are available in the market, but nothing promises to cure this deadly disease 100%. But Accelerated Evolution Biotechnologies Ltd (AEBi), founded in 2000 from the ITEK Weizmann technology incubator has made bold claims to cure the disease completely. 
In an interview to a leading daily, Aridor, chairman of the board of AEBi, has asserted that their cancer cure will be effective from the very first day and will last for a few weeks. Additionally, their medicines will have “no or minimal side-effects”. He further said that the cure for cancer will be available at a much lower cost than other treatments available in the market. 
The treatment which the biotech company calls MuTaTo (multi-target toxin) is based on SoAP technology, which belongs to the phage display group of technologies. 
CEO of the biotech company Dr Ilan Morad said they started with identifying why other cancer-related drugs and treatment are not working and then they looked for an effective way to counter it. 

Most cancer drugs attack a specific target or on the cancer cell, but MuTaTo attacks the cancer cell's receptors from three different directions.

“Instead of attacking receptors one at a time, we attack receptors three at a time. Not even cancer can mutate three receptors at one time," said Morad.

After a successful mice trail, Morad said that the company is now preparing to try medicines on humans through this year. Following this, they will introduce the medicine in the market by next year.

The claim made by the biotech company sounds very exciting when around 18. 1 million new cases of cancer are being diagnosed every year across the globe.

© Times of India

1 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

AMIT Feb 5 2019, At 09:52 am

Really its a fantastic news and this will be going to a great gift to human being to fight with deadly disease.

Related News


Teijing to supply carbon fiber intermediate material for Boeing

TOKYO, JAPAN: Teijin Limited announced that its Tenax carbon fiber and carbon fiber thermoplastic unidirectional pre-impregnated tape w ...

Read more
Saudi Aramco, Total partners with Daelim for polyisobutylene plant

DHAHRAN, SAUDI ARABIA: Saudi Aramco with its partner Total announced the signing of a MoU with Daelim. Under the MoU, Daelim is planning to build a ne ...

Read more
Gujarat government signs MoU with BioChem for Bio-Refinery

GANDHINAGAR, INDIA: The Gujarat government signed an MoU with US based BioChem USA LLC to establish a Bio-Refinery in Dahej PCPIR and an Eth ...

Read more
Eni, Pertamina signs MoU on new collaboration opportunities

ROME, ITALY: Pertamina and Eni signed a MoU to investigate synergies of their respective technologies, expertises and for jointly evaluating new ...

Read more
Covestro introduces high temperature polycarbonate syringe closures

LEVERKUSEN, GERMANY: Covestro has launched the adapter of Gerresheimer’s Gx syringes for later screwing in the needle and in the cap made f ...

Read more
Nouryon launches biodegradable defoamer for cleaning applications

AMSTERDAM, NETHERLANDS: Nouryon has launched a more sustainable, watermiscible defoamer, Ethylan TB345, that will help household and industrial cleani ...

Read more